Cargando…
Differences in High‐ and Low‐Value Cardiovascular Testing by Health Insurance Provider
BACKGROUND: Quality of care incentives and reimbursements for cardiovascular testing differ between insurance providers. We hypothesized that there are differences in the use of guideline‐concordant testing between Medicaid versus commercial insurance patients <65 years, and between Medicare Adva...
Autores principales: | Kini, Vinay, Mosley, Bridget, Raghavan, Sridharan, Khazanie, Prateeti, Bradley, Steven M., Magid, David J., Ho, P. Michael, Masoudi, Frederick A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955432/ https://www.ncbi.nlm.nih.gov/pubmed/33506684 http://dx.doi.org/10.1161/JAHA.120.018877 |
Ejemplares similares
-
Trends in High- and Low-Value Cardiovascular Diagnostic Testing in Fee-for-Service Medicare, 2000-2016
por: Kini, Vinay, et al.
Publicado: (2019) -
Meta‐Analysis of Medication Adherence Interventions Among Heart Failure Patients: The Lumpers Make Their Case
por: Khazanie, Prateeti, et al.
Publicado: (2016) -
Forced Choices: Ethical Challenges in Cardiology During the COVID-19 Pandemic
por: Khazanie, Prateeti, et al.
Publicado: (2020) -
Trends in Short‐, Intermediate‐, and Long‐Term Mortality Following Hospitalization for Myocardial Infarction Among Medicare Beneficiaries, 2008 to 2018
por: Kini, Vinay, et al.
Publicado: (2023) -
Clinical Effectiveness of Cardiac Resynchronization Therapy Versus Medical Therapy Alone Among Patients With Heart Failure: Analysis of the ICD Registry and ADHERE
por: Khazanie, Prateeti, et al.
Publicado: (2014)